Combination therapy with tumor cell-pulsed dendritic cells and activated lymphocytes for patients with disseminated carcinomas
/in Dendritic Cells, International PublicationsDendritic cells pulsed with total tumor RNA for activation NK-like T cells against glioblastoma multiforme
/in Glioblastoma, International PublicationsEfficient stimulation of HIV-1-specific T cells using dendritic cells electroporated with mRNA encoding autologous HIV-1 Gag and Env proteins
/in HIV/AIDS, International PublicationsCombined immunocell therapy using activated lymphocytes and monocyte-derived dendritic cells for malignant melanoma
/in International Publications, Malignant MelanomaImmunization using autologous dendritic cells pulsed with the melanoma-associated antigen gp100-derived G280-9V peptide elicits CD8+ immunity
/in International Publications, Malignant MelanomaEfficacy of immuno-cell therapy in patients with advanced pancreatic cancer
/in International Publications, Pancreatic CancerMedullary thyroid carcinoma: autologous tumor cell lines for dendritic cell vaccination
/in Dendritic Cells, International Publications, Thyroid CancerHyperthermia combined with radiation in treatment of locally advanced prostate cancer is associated with a favourable toxicity profile
/in Hyperthermia, International Publications, Prostate CancerPhase I/II trial of intravenous NDV-HUJ oncolytic virus in recurrent glioblastoma multiforme
/in Glioblastoma, International Publications, Newcastle Disease Virus
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Die IOZK Immuntherapie
Aktuelles und Int. Publikationen
- WT1-mRNA dendritic cell vaccination of patients with glioblastoma multiforme, malignant pleural mesothelioma, metastatic breast cancer, and other solid tumors: type 1 T-lymphocyte responses are associated with clinical outcome
- Autologous tumor lysate-loaded dendritic cell vaccination in glioblastoma patients: a systematic review of literature
- Retrospective Analysis of HLA Class II-Restricted Neoantigen Peptide-Pulsed Dendritic Cell Vaccine for Breast Cancer